IP Library Granted Patent US 9,029,083
Granted Patent B2
US 9,029,083 · App. 11/665,030 · Granted May 12, 2015

Vitro evolution in microfluidic systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,029,083
App. No.
11/665,030
Granted
May 12, 2015
Kind
B2
Abstract

The invention describes a method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising the steps of: (a) compartmentalising genetic elements into microcapsules; and (b) sorting the genetic elements which express the gene product having the desired activity; wherein at least one step is under microfluidic control. The invention enables the in vitro evolution of nucleic acids and proteins by repeated mutagenesis and iterative applications of the method of the invention.

Claims (13)

1. A method for providing a library of entities, comprising the steps of:

producing a plurality of aqueous droplets by partitioning an aqueous fluid as it is flowing through a channel with an immiscible continuous phase that comprises a fluorinated oil and a fluorinated polymer surfactant, each droplet comprising at least one entity; and

pooling the droplets into one or more common compartments that have larger cross-sectional areas than the channel that slows the velocity of the droplets as compared to their velocity within the channel, wherein the droplets contact each other but do not fuse within the one or more common compartments, thereby providing a library of encapsulated entities.

2. The method of claim 1 , wherein the entities are nucleic acids, proteins, or cells.

3. The method of claim 2 , wherein the nucleic acids are primers for a polymerase chain reaction (PCR).

4. The method of claim 1 , wherein the entities are labeled.

5. The method of claim 4 , wherein the entities are optically labeled.

6. The method of claim 1 , wherein the entities are fluorescently labeled antibodies.

7. The method of claim 1 , wherein the entities are chemically labeled antibodies.

8. The method of claim 1 , wherein the droplets are unable to fuse due to the presence of a surfactant.

9. The method of claim 1 , wherein the droplets are separated by the immiscible continuous phase in the channel.

10. The method of claim 1 , wherein the oil is a perfluorinated oil.

11. The method of claim 1 , wherein the droplets are monodisperse with respect to each other.

Assignments (4)
CONFIRMATORY LICENSE Recorded May 13, 2020
From: HARVARD UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 052655/0377 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2018
From: MEDICAL RESEARCH COUNCIL
To: UNITED KINGDOM RESEARCH AND INNOVATION
Reel/Frame 046469/0108 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2009
From: LINK, DARREN; AHN, KEUNHO; WEITZ, DAVID; BIBETTE, JEROME
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 022541/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2009
From: GRIFFITHS, ANDREW
To: MEDICAL RESEARCH COUNCIL
Reel/Frame 022541/0267 →